Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, CV2 2DX, UK.
Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UK.
BMC Med. 2023 Apr 19;21(1):154. doi: 10.1186/s12916-023-02857-z.
Dysfunctional adipose tissue (AT) is known to contribute to the pathophysiology of metabolic disease, including type 2 diabetes mellitus (T2DM). This dysfunction may occur, in part, as a consequence of gut-derived endotoxaemia inducing changes in adipocyte mitochondrial function and reducing the proportion of BRITE (brown-in-white) adipocytes. Therefore, the present study investigated whether endotoxin (lipopolysaccharide; LPS) directly contributes to impaired human adipocyte mitochondrial function and browning in human adipocytes, and the relevant impact of obesity status pre and post bariatric surgery.
Human differentiated abdominal subcutaneous (AbdSc) adipocytes from participants with obesity and normal-weight participants were treated with endotoxin to assess in vitro changes in mitochondrial function and BRITE phenotype. Ex vivo human AbdSc AT from different groups of participants (normal-weight, obesity, pre- and 6 months post-bariatric surgery) were assessed for similar analyses including circulating endotoxin levels.
Ex vivo AT analysis (lean & obese, weight loss post-bariatric surgery) identified that systemic endotoxin negatively correlated with BAT gene expression (p < 0.05). In vitro endotoxin treatment of AbdSc adipocytes (lean & obese) reduced mitochondrial dynamics (74.6% reduction; p < 0.0001), biogenesis (81.2% reduction; p < 0.0001) and the BRITE phenotype (93.8% reduction; p < 0.0001). Lean AbdSc adipocytes were more responsive to adrenergic signalling than obese AbdSc adipocytes; although endotoxin mitigated this response (92.6% reduction; p < 0.0001).
Taken together, these data suggest that systemic gut-derived endotoxaemia contributes to both individual adipocyte dysfunction and reduced browning capacity of the adipocyte cell population, exacerbating metabolic consequences. As bariatric surgery reduces endotoxin levels and is associated with improving adipocyte functionality, this may provide further evidence regarding the metabolic benefits of such surgical interventions.
功能失调的脂肪组织(AT)已知会导致代谢疾病的病理生理学,包括 2 型糖尿病(T2DM)。这种功能障碍可能部分是由于肠道来源的内毒素血症导致脂肪细胞线粒体功能改变,并减少 BRITE(白色脂肪中的棕色)脂肪细胞的比例。因此,本研究旨在探讨内毒素(脂多糖;LPS)是否直接导致人类脂肪细胞线粒体功能受损和人类脂肪细胞的棕色化,并研究肥胖症患者接受减重手术后肥胖状态前后的相关影响。
从肥胖和正常体重参与者的腹部皮下(AbdSc)分化脂肪细胞中提取人源分化的 AbdSc 脂肪细胞,用内毒素处理以评估体外线粒体功能和 BRITE 表型的变化。从不同组别的参与者(正常体重、肥胖、减重手术后 6 个月)的人体 AbdSc 脂肪组织中提取体外脂肪组织(正常体重、肥胖、减重手术后),进行类似的分析,包括循环内毒素水平。
体外 AbdSc 脂肪细胞(瘦和肥胖)的分析(瘦和肥胖、减重手术后的体重减轻)表明,全身内毒素与 BAT 基因表达呈负相关(p<0.05)。内毒素处理 AbdSc 脂肪细胞(瘦和肥胖)减少线粒体动力学(74.6%减少;p<0.0001)、生物发生(81.2%减少;p<0.0001)和 BRITE 表型(93.8%减少;p<0.0001)。瘦 AbdSc 脂肪细胞对肾上腺素信号的反应比肥胖 AbdSc 脂肪细胞更敏感;尽管内毒素减轻了这种反应(92.6%减少;p<0.0001)。
综上所述,这些数据表明,全身肠道来源的内毒素血症既导致个体脂肪细胞功能障碍,又导致脂肪细胞群体的棕色化能力降低,从而加剧代谢后果。由于减重手术可降低内毒素水平,并与改善脂肪细胞功能有关,这可能为这种手术干预的代谢益处提供进一步的证据。